Cargando…

Precision Medicine in Type 1 Diabetes

Type 1 diabetes is a complex, chronic disease in which the insulin-producing beta cells in the pancreas are sufficiently altered or impaired to result in requirement of exogenous insulin for survival. The development of type 1 diabetes is thought to be an autoimmune process, in which an environmenta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalek, Dominika A., Onengut-Gumuscu, Suna, Repaske, David R., Rich, Stephen S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393845/ https://www.ncbi.nlm.nih.gov/pubmed/37538198 http://dx.doi.org/10.1007/s41745-023-00356-x

Ejemplares similares

Dynamic changes in immune gene co-expression networks predict development of type 1 diabetes
por: Brænne, Ingrid, et al.
Publicado: (2021)

A Genome-Wide Assessment of the Role of Untagged Copy Number Variants in Type 1 Diabetes
por: Zanda, Manuela, et al.
Publicado: (2014)

Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
por: Newman, Jeremy R. B., et al.
Publicado: (2023)

Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes
por: Ge, Yan, et al.
Publicado: (2016)

Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes
por: Newman, Jeremy R.B., et al.
Publicado: (2017)

Leveraging type 1 diabetes human genetic and genomic data in the T1D Knowledge Portal
por: Kudtarkar, Parul, et al.
Publicado: (2023)

Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal
por: Kudtarkar, Parul, et al.
Publicado: (2023)

TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study
por: Miller, Rachel G, et al.
Publicado: (2023)

Precision medicine in type 1 diabetes
por: Carr, Alice L. J., et al.
Publicado: (2022)

DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study
por: Miller, Rachel G., et al.
Publicado: (2023)

Evidence for two independent associations with type 1 diabetes at the 12q13 locus
por: Keene, Keith L., et al.
Publicado: (2011)

The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway
por: Tran, Paul MH., et al.
Publicado: (2021)

A Method for Gene-Based Pathway Analysis Using Genomewide Association Study Summary Statistics Reveals Nine New Type 1 Diabetes Associations
por: Evangelou, Marina, et al.
Publicado: (2014)

Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes
por: Onengut-Gumuscu, Suna, et al.
Publicado: (2020)

A Human Type 1 Diabetes Susceptibility Locus Maps to Chromosome 21q22.3
por: Concannon, Patrick, et al.
Publicado: (2008)

The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective
por: Rich, Stephen S., et al.
Publicado: (2016)

Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity
por: Gutierrez-Achury, Javier, et al.
Publicado: (2015)

Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2015)

Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes
por: Cooper, Nicholas J., et al.
Publicado: (2015)

Fine Mapping and Functional Studies of Risk Variants for Type 1 Diabetes at Chromosome 16p13.13
por: Tomlinson, M. Joseph, et al.
Publicado: (2014)

Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2016)

Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens
por: Jia, Xiaoming, et al.
Publicado: (2013)

An Oxylipin-Related Nutrient Pattern and Risk of Type 1 Diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)
por: Buckner, Teresa, et al.
Publicado: (2023)

Depressive Symptoms and Glycemic Control in Adolescents With Type 1 Diabetes: Mediational role of blood glucose monitoring
por: McGrady, Meghan E., et al.
Publicado: (2009)

Microbiota alteration is associated with the development of stress-induced despair behavior
por: Marin, Ioana A., et al.
Publicado: (2017)

Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families
por: Hippich, Markus, et al.
Publicado: (2019)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review
por: Felton, Jamie L., et al.
Publicado: (2023)

Genetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains
por: Wang, Qian, et al.
Publicado: (2015)

Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
por: Mutie, Pascal M., et al.
Publicado: (2017)

Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
por: Törn, Carina, et al.
Publicado: (2022)

Transform diabetes care with precision medicine
por: Kannan, Sharumathy, et al.
Publicado: (2023)

A roadmap to achieve pharmacological precision medicine in diabetes
por: Florez, Jose C., et al.
Publicado: (2022)

From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes
por: den Hollander, Nicoline H. M., et al.
Publicado: (2022)

Precision medicine in diabetes prevention, classification and management
por: Xie, Fangying, et al.
Publicado: (2018)

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
por: Onengut-Gumuscu, Suna, et al.
Publicado: (2015)

Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)

Next steps in the identification of gene targets for type 1 diabetes
por: Grant, Struan F. A., et al.
Publicado: (2020)

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
por: Coco, Celeste, et al.
Publicado: (2019)

Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
por: Udler, Miriam S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ls5aniqv9ut2boc0qa7q6bcqdp